-
Mashup Score: 0
Among 287 patients across multiple solid tumor indications, YL201 had an objective response rate of 40.8%, with a disease control rate of 83.6%.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet
-
Mashup Score: 0
The liposomal formulation of gemcitabine may enhance anti-tumor activity by increasing plasma half-life and improving targeted delivery to tumors.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet-
The FDA granted orphan drug designation to FF-10832, an investigational liposomal formulation of gemcitabine, for the treatment of patients with biliary tract cancer. #oncology https://t.co/hxbIaRqnDa
-
-
Mashup Score: 4The OncFive: Top Oncology Articles for the Week of 6/29 - 2 day(s) ago
The FDA grants approval to sunvozertinib in NSCLC and linvoseltamab in myeloma and removes REMS requirements for approved CAR T-cell therapies.
Source: www.onclive.comCategories: General Medicine NewsTweet-
This is your sign đ to catch up on last week's top 5 #oncology stories, including: âď¸ 2 FDA approvals âď¸ An FDA regulatory rundown âď¸ Updates from the phase 3 FORTITUDE-101 trial Read it all here: https://t.co/9wtaU7SN2P https://t.co/i8FQ1Gmg9K
-
-
Mashup Score: 2
ATR04-484 showed inhibition of both methicillin-sensitive and methicillin-resistant Staphylococcus aureus bacteria strains, which are associated with rash.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet-
ATR04-484 inhibited both methicillin-sensitive and methicillin-resistant Staphylococcus aureus bacteria strains, which are associated with rash in patients with cancer. #oncology | @YaleCancer https://t.co/UzwtrTIGkI https://t.co/DoSKcwGTPR
-
-
Mashup Score: 3Padeliporfin Vascular Targeted Photodynamic Therapy Safely Produces High Response Rates in Low-Grade Upper Tract Urothelial Cancer - 3 day(s) ago
Padeliporfin vascular targeted photodynamic therapy was highly active with a tolerable safety profile in low-grade upper tract urothelial cancer.
Source: www.onclive.comCategories: General Medicine NewsTweet-
Padeliporfin Vascular Targeted Photodynamic Therapy Safely Produces High Response Rates in Low-Grade Upper Tract Urothelial Cancer #oncology https://t.co/sTVLcMBqXs
-
-
Mashup Score: 4
Cancer parametric PET imaging with radioactive tracers is reduced from an hour to 20 minutes
Source: www.onclive.comCategories: General Medicine NewsTweet-
EXPLORER Shrinks The Time it Takes for Imaging to Spot Cancer @UCDavisHealth #oncology https://t.co/hHZzfULNMq
-
-
Mashup Score: 0
A WeCanWork study showed that men who work laborious jobs need additional support during and after cancer treatment.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet-
A recent study showed that men who worked physically demanding jobs needed additional well-being support during and after cancer treatment. #oncology | @CUCancerCenter @ColoradoSPH https://t.co/2tNgTjnUoz
-
-
Mashup Score: 4
PATHFINDER 2 data build upon bolstered cancer detection rates by the multi-cancer early detection test found in a previously published PATHFINDER study.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet-
The addition of the Galleri multicancer early detection test to SOC single cancer screening substantially increased cancer detection and positive predictive value vs SOC alone. #oncology https://t.co/OaBv2XC3ZP
-
-
Mashup Score: 268Ga-FAPI-46 PET Acts as Biomarker for FAP-Positive Cancers - 4 day(s) ago
68Ga-FAPI-46 PETâs SUVpeak was highest in patients with pancreaticobiliary cancer, sarcoma, lung cancer, and esophageal/gastrointestinal cancer.
Source: www.cancernetwork.comCategories: General Medicine NewsTweet-
68Ga-FAPI-46 PET met the primary end point of positive predictive value in the detection of fibroblast activation proteinâexpressing cancer in patients with various tumor types. #oncology https://t.co/SvpGEnHrd6
-
-
Mashup Score: 15Improving the Alliance Between Oncologists and Primary Care Providers: A Call for Collaborative Action - 4 day(s) ago
Experts and patients alike would agree that navigating the current fragmented U.S. health-care system is not an easy task. One component of that disconnection may center on the relationship between on…
Source: ascopost.comCategories: General Medicine NewsTweet-
Andrea Porpiglia, MD, of Fox Chase Cancer Center, emphasizes the importance of stronger collaboration between oncologists and primary care providers to improve patient care across the cancer journey. Read more in The ASCO Post: https://t.co/hVh2Rv4iXp #Oncology @AndreaSurg1
-
YL201, a B7H3-targeting ADC, demonstrated an acceptable safety profile and early efficacy in patients with advanced solid tumors previously treated with at least 1 standard therapy. #oncology https://t.co/AhPTVLImKG